viernes, 5 de agosto de 2016

Clinical Trials Search Results - National Cancer Institute

Clinical Trials Search Results - National Cancer Institute

National Cancer Institute banner



National Cancer Institute



Surgery Alone, Surgery With Cyclophosphamide, Vinblastine, and Prednisolone (CVP), or CVP Alone in Treating Young Patients With Stage IA or Stage IIA Nodular Lymphocyte-Predominant Hodgkin Lymphoma
Status: Active
Phase: Phase IV
Type: Treatment
Age: 17 and under
Trial IDs: CDR0000667369, NCI-2014-02026, EU-21011, EUDRACT-2007-004092-19, EURONET-PHL-LP1, NCT01088750
Comparison Of 2 Doses Of Temsirolimus (Torisel) In Patients With Mantle Cell Lymphoma
Status: Active
Phase: Phase IV
Type: Treatment
Age: 18 and over
Trial IDs: 3066K1-4438, NCI-2014-00131, 2009-015498-11, B1771007, NCT01180049
Transurethral Resection of Bladder Tumors Using PK Button Vaporization Electrode or Monopolar Loop Electrocautery in Treating Patients with Bladder Cancer
Status: Active
Phase: Phase IV
Type: Treatment
Age: 18 to 89
Trial IDs: WCI2119-11, NCI-2013-00065, IRB00053735, NCT01567462
Safety and Efficacy Study of the Xoft® Axxent® eBx™ IORT System
Status: Active
Phase: Phase IV
Type: Treatment
Age: 40 and over
Trial IDs: CTPR-0009, NCI-2013-01601, NCT01644669
An Extension (Rollover) Study of Vemurafenib in Patients With BRAF V600 Mutation-Positive Malignancies Previously Enrolled in an Antecedent Vemurafenib Protocol
Status: Active
Phase: Phase IV
Type: Treatment
Age: 18 and over
Trial IDs: GO28399, NCI-2013-01160, 2012-003144-80, NCT01739764
Preoperative Biliary Drainage in Resectable Pancreatic or Periampullary Cancer
Status: Active
Phase: Phase IV
Type: Treatment
Age: 18 and over
Trial IDs: CDM00047339, NCI-2016-00348, E7059, NCT01774019
Everolimus Roll-over Protocol for Patients Who Have Completed a Previous Novartis-sponsored Everolimus Study.
Status: Active
Phase: Phase IV
Type: Treatment
Age: Any age
Trial IDs: CRAD001C2X01B, NCI-2013-01151, NCT01789281
Sorafenib Tosylate in Treating Patients with Advanced Liver Cancer and Hepatitis C Infection
Status: Active
Phase: Phase IV
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 12-213, NCI-2013-01103, NCT01849588
Cancer Venous Thromboembolism (VTE)
Status: Active
Phase: Phase IV
Type: Natural history/Epidemiology
Age: 18 and over
Trial IDs: DU176b-D-U311, NCI-2015-01358, 2014-004708-30, NCT02073682
Observational Study for the Evaluation of Long-term Safety of Radium-223 Used for the Treatment of Metastatic Castration Resistant Prostate Cancer
Status: Active
Phase: Phase IV
Type: Natural history/Epidemiology
Age: 18 and over
Trial IDs: 16913, NCI-2014-02038, NCT02141438
Safety and Efficacy Study of Abraxane in Combination With Carboplatin to Treat Advanced NSCL Cancer in the Elderly
Status: Active
Phase: Phase IV
Type: Treatment
Age: 70 and over
Trial IDs: ABI-007-NSCL-005, NCI-2014-02488, NCT02151149
Behavioral Counseling and Nicotine Replacement Therapy or Varenicline in Helping Smokers Quit
Status: Active
Phase: Phase IV
Type: Behavioral study, Biomarker/Laboratory analysis, Prevention
Age: 18 to 65
Trial IDs: 2014-0207, NCI-2014-01485, NCT02162849
Light Sedation or Intubated General Anesthesia in Reducing Complications and Length of Hospital Stay in Patients With Brain Cancer Undergoing Craniotomy
Status: Active
Phase: Phase IV
Type: Supportive care, Treatment
Age: 19 and over
Trial IDs: OSU-12161, NCI-2014-01110, 2014C0007, NCT02193568
Safety And Efficacy Study Of Bosutinib In Patients With Philadelphia Chromosome Positive Chronic Myeloid Leukemia Previously Treated With One Or More Tyrosine Kinase Inhibitors
Status: Active
Phase: Phase IV
Type: Treatment
Age: 18 and over
Trial IDs: B1871039, NCI-2014-02251, 2013-003250-25, NCT02228382
Varenicline and Nicotine Replacement Therapy for Initial Smoking Cessation and Treatment in Smokers
Status: Active
Phase: Phase IV
Type: Behavioral study, Prevention
Age: 18 to 65
Trial IDs: 2014-0213, NCI-2015-00610, NCT02271919
Perampanel in Lowering the Incidence of Seizures in Patients with Primary Glioma
Status: Active
Phase: Phase IV
Type: Supportive care
Age: 18 and over
Trial IDs: Pro00055609, NCI-2015-00365, NCT02363933
Vismodegib in Treating Patients with Locally Advanced or Recurrent Orbital or Periocular Basal Cell Cancer
Status: Active
Phase: Phase IV
Type: Treatment
Age: 18 and over
Trial IDs: UMCC 2014.022, NCI-2015-00927, HUM00082579, ML29160, NCT02436408
Continuous Infusion of Ropivacaine Hydrochloride in Reducing Pain after Surgery in Patients with Bladder Cancer
Status: Not yet active
Phase: Phase IV
Type: Health services research, Supportive care
Age: 18 and over
Trial IDs: 4B-14-4, NCI-2015-00279, NCT02438852
A Study of Enzalutamide Re-treatment in Metastatic Castration-resistant Prostate Cancer After Docetaxel Treatment in Patients Who Have Previously Received Enzalutamide
Status: Active
Phase: Phase IV
Type: Treatment
Age: 18 and over
Trial IDs: 9785-MA-1008, NCI-2015-01197, NCT02441517
Study Evaluating The Safety Of Subcutaneous Methylnaltrexone In Treatment Of Opioid-Induced Constipation
Status: Active
Phase: Phase IV
Type: Treatment
Age: 18 and over
Trial IDs: 3200K1-4001, NCI-2010-01965, B2541006, NCT00672139
Efficacy and Safety of Ferriprox® in Patients With Sickle Cell Disease or Other Anemias
Status: Active
Phase: Phase IV
Type: Treatment
Age: 2 and over
Trial IDs: LA38-0411, NCI-2014-01229, NCT02041299
Regadenoson Stress Echocardiogram in Detecting Coronary Artery Disease in Patients with Cancer
Status: Active
Phase: Phase IV
Type: Diagnostic
Age: 18 to 80
Trial IDs: 2013-0881, NCI-2014-01162, NCT02130453
Informing Tobacco Treatment Guidelines for African American Non-Daily Smokers
Status: Active
Phase: Phase IV
Type: Biomarker/Laboratory analysis, Prevention
Age: 18 and over
Trial IDs: STUDY00001602, NCI-2015-01331, AD-1310-08709, NCI-2015-00937, NCT02244918
An Expanded Access, Open-Label Study of Obinutuzumab (GA101) Plus Chlorambucil in Patients With Previously Untreated Chronic Lymphocytic Leukemia
Status: Not yet active
Phase: Phase IV
Type: Treatment
Age: 18 and over
Trial IDs: ML28979, NCI-2013-02161, NCT01868893
An Expanded Access Study of Atezolizumab in Participants With Locally Advanced or Metastatic Urothelial Carcinoma After Failure With Platinum-Containing Chemotherapy
Status: Not yet active
Phase: Phase IV
Type: Treatment
Age: 18 and over
Trial IDs: ML29725, NCI-2015-01995, NCT02589717

No hay comentarios:

Publicar un comentario